Although being the second-most frequently mutated oncogene in GIST (up to 10%), mutations in PDGFR were rare in this study, which could be due to the fact that PDGFRA- mutated GISTs tend to have a lower risk of recurrence [30]. The gene discussed is PDGFRB; the disease is gastrointestinal stromal tumor.